Intestinal Availability and Metabolic Effects of Dietary Camelina Sphingolipids during the Metabolic Syndrome Onset in Mice

J Agric Food Chem. 2020 Jan 22;68(3):788-798. doi: 10.1021/acs.jafc.9b06829. Epub 2020 Jan 7.

Abstract

Sphingolipids appear as a promising class of components susceptible to prevent the onset of the metabolic syndrome (MetS). Gut availability and effects of Camelina sativa sphingolipids were investigated in a mouse model of dietary-induced MetS. Seed meals from two Camelina sativa lines enriched, respectively, in C24- and C16-NH2- glycosyl-inositol-phosphoryl-ceramides (NH2GIPC) were used in hypercaloric diets. After 5 weeks on these two hypercaloric diets, two markers of the MetS were alleviated (adiposity and insulin resistance) as well as inflammation markers and colon barrier dysfunction. A more pronounced effect was observed with the C16-NH2GIPC-enriched HC diet, in particular for colon barrier function. Despite a lower digestibility, C16-NH2GIPC were more prevalent in the intestine wall. Sphingolipids provided as camelina meal can therefore counteract some deleterious effects of a hypercaloric diet in mice at the intestinal and systemic levels. Interestingly, these beneficial effects seem partly dependent on sphingolipid acyl chain length.

Keywords: Camelina sativa; acyl chain; digestibility; metabolic syndrome; sphingolipid.

MeSH terms

  • Animal Feed / analysis
  • Animals
  • Camellia / chemistry*
  • Diet, High-Fat / adverse effects
  • Humans
  • Intestinal Mucosa / metabolism*
  • Male
  • Metabolic Syndrome / metabolism
  • Metabolic Syndrome / prevention & control*
  • Mice
  • Mice, Inbred C57BL
  • Plant Extracts / chemistry
  • Plant Extracts / metabolism*
  • Sphingolipids / chemistry
  • Sphingolipids / metabolism*

Substances

  • Plant Extracts
  • Sphingolipids